Advertisement
Home Tags Multiple Myeloma

Tag: Multiple Myeloma

Construction Workers: Basic Safety Tips

Risk for MGUS Up in WTC-Exposed Rescue/Recovery Workers

Risk for myeloma precursor disease, monoclonal gammopathy of undetermined significance, increased among WTC-exposed workers

Polypharmacy Prevalent Among Older Adults With Blood Cancers

Taking eight or more medications strongly associated with frailty; odds of being prefrail, frail increased with each additional med

Caregivers of Multiple Myeloma Patients Face Mental Health Issues

Among caregivers of multiple myeloma patients, 44.1 percent and 24.4 percent report anxiety and PTSD symptoms, respectively

A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma

In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation

Frailty Mars Outcomes After aHSCT in Lymphoid Malignancies

Links found for frailty with in-hospital mortality, prolonged length of stay for patients with NHL, HL, MM undergoing aHSCT

Racial Disparities Persist in Multiple Myeloma Care, Outcomes

Hispanics have higher MM-related in-hospital mortality; recent decline seen in in-hospital mortality for all except NH-Blacks

Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients

Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine

Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL

Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma

Guidance Offered for Improving Diversity in Multiple Myeloma Trials

Ways to improve representation of African Americans in clinical trials could be extrapolated to other underrepresented groups

Guidelines Developed for Diabetes Management in CKD

Renal Insufficiency May Worsen Multiple Myeloma Outcomes

Risk for disease progression or death increased for those with renal insufficiency in relapsed/refractory, newly diagnosed MM